Journal of Clinical Trials
Open Access

Department of Clinical Science, Siberian State Medical University, Tomsk, Russian Federation

Publications

• Research Article   
  Intracoronary Administration of Epinephrine and Verapamil in the Refractory No-Reflow Phenomenon in Patients with Acute Myocardial Infarction: Study Protocol for an Open-Label Randomized Controlled Trial
  Author(s): Stanislav V Dil*, Vyacheslav V Ryabov and Evgeny V Vyshlov
  
  Background: Refractory no-reflow syndrome can still occur, negating many of the benefits of restoring culprit vessel patency, and is associated with a worse in-hospital and long-term prognosis. Epinephrine may at lower doses exert potent beta receptor agonist properties that mediate coronary vasodilatation. The trial aims to estimate the efficacy and safety of the administration of intracoronary adrenalin, verapamil, as well as their combination versus standard treatment in patients with STEMI and refractory coronary no-reflow. Methods/Design: Consecutive patients with STEMI and refractory no-reflow syndrome will be randomized into 4 groups: Standard therapy only, intracoronary administration of epinephrine, verapamil, epinephrine+verapamil. All patients will undergo an assessment of epicardial blood flow using TIMI score, pe.. View More»
  DOI: 10.35248/2167-0870.23.13.527

  Abstract HTML PDF